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Abstract
 .  .The effects of agents modulating the cytoskeleton, taxol microtubuli stabilizing , vinblastine microtubuli destabilizing
 .  y6 .and cytochalasin D actin destabilizing 10 M each on enzyme and ATP release as well as on irreversible cell injury
  ..were investigated in isolated perfused hypoxic and reoxygenated rat hearts. Enzyme creatine kinase CK and ATP
concentration were assayed in the interstitial transudate and venous effluent. Irreversible cell injury was determined from
 .trypan blue uptake and nuclear staining NS of cardiomyocytes in histologic sections. ATP release from nonneuronal cells
was only detectable in the interstitial transudate and was not significantly altered by the agents. In controls total CK release
 .about 4% of total CK exceeded the percentage of irreversibly injured cells by a factor of 8. Taxol and cytochalasin D
abolished the hypoxiarreoxygenation induced interstitial CK release and reduced total CK release to a highly significant
extent. The percentage of irreversible injured cells was even more diminished by these agents resulting in a ratio of CKrNS
of 40. The effect of cytochalasin D apparently is the consequence of decreased contractile performance as shown by
 .analogous depression by butonedione monoxine BDM , whereas contractile activity was not altered by taxol. Vinblastine
had no influence on CK release but increased the number of irreversibly injured cells significantly. In conclusion,
cytoskeletal elements apparently participate in the hypoxiarreoxygenation induced process of release of cytosolic enzymes
 .CK and irreversible injury in a different way and extent. Taxol exhibits a cytoprotective effect in isolated perfused rat
hearts as evaluated by the extent of enzyme release and irreversible cell injury. q 1997 Elsevier Science B.V.
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1. Introduction
The mechanisms of enzyme release and irre-
versible cell injury, e.g. under hypoxia and ischemia
are still poorly understood and various processes
w xmight be involved. In a preceding study 1 we
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demonstrated that enzyme release is not necessarily a
sign of irreversible cell injury, since the percentage of
enzyme release can exceed the percentage of irre-
versible injury by more than one order of magnitude.
Thus, the mechanisms underlying these phenomena
might differ substantially. Selective enzyme release
might result from bleb formation at the sarcolemma,
which is likely to involve cytoskeletal elements. On
the other hand, the cytoskeleton apparently con-
w xtributes to cell injury 2 , e.g. by favouring cell
w xfragility 3 . We therefore investigated the influence
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of cytoskeleton modulating agents, taxol microtubuli
.  .stabilizing , vinblastine microtubuli destabilizing ,
 .cytochalasin D actin destabilizing on hypoxia in-
duced alterations of CK-release and cell death in
isolated perfused rat hearts. We observed, e.g. under
the influence of taxol, a remarkable reduction of
enzyme release as well as of irreversible cell injury.
2. Materials and methods
The studies were carried out in isolated perfused
 . rat hearts female Sprague Dawley 200–260 g Per-
 .fusate: Krebs–Ringer–Bicarbonate KHB 2 mM
Caqq, supplemented with 5.6 mM Glucose and
.  .1.2 mM Pyruvate . Perfusion 388C of the hearts was
performed in a non-recirculating system according to
Langendorff’s technique constant pressure, 65 mm
.Hg . A thin-walled latex balloon, formed according
to an intraventricular cast of hearts of animals of the
same size and mounted on a rigid catheter, was
inserted into the cavity of the left ventricle via the
mitral valve. Left ventricular pressure, and heart rate
were monitored by using a chart recorder. The initial
volume of the balloon was adjusted to an end-di-
astolic pressure of zero by using a microliter syringe.
The heart was then placed with its apex uppermost in
a water-jacketed, thermostated and moistened cham-
ber and the ventricles were covered with a thin-walled
floppy latex cap under which the interstitial transu-
date emerging on the surface of the heart was sam-
 w x.pled by slight suction for details see 4 .
 .The total amount of creatine kinase CK released
was estimated from the entire perfusate passing the
heart during the experimental period. Collection of
the perfusate was started as soon as possible after the
preparation, i.e. after about 3 min following the start
of preparation. This amount of CK is expressed as
percentage of the total amount of CK which can be
 .released from the heart 680 " 55 Urg after se-ww
vere injury induced by Ca paradox: intermittent
qq qq w x.Ca and Mg free perfusion 5 . It is equivalent
to about 78% of the total CK content of an homoge-
nized heart. The number of irreversibly injured car-
diac myocytes was estimated from trypan blue stain-
 .ing of nuclei. Trypan blue, a polar anionic dye of a
molecular weight of 960 Da passes only irreversibly
w xinjured cell membranes and binds to nuclei 6,7 . This
staining allows embedding and staining for micro-
scopic evaluation. At the end of the experiments the
hearts were perfused with a perfusate containing 0.1%
trypan blue for 10 min. Subsequently, excess dye was
removed by perfusion with 0.6% formaldehyde in
KHB for 3 min and eventually immersed and fixed in
1.6% formaldehyde. The hearts were embedded in
paraffin in the usual procedure. Six cross-sections
and six frames per cross-section were used to evalu-
ate the number of trypan blue stained nuclei.
 .The number of trypan blue stained nuclei NS is
expressed in percent of the total number of nuclei
 .about 300 per frame as determined by counting the
 .total number of nuclei stained with hematoxilin in
corresponding sections. The ratio of percent CK re-
lease to percent trypan blue stained nuclei was used
to estimate the relationship of reversibly to irre-
versibly damaged myocytes.
For ATP measurement the interstitial effluent col-
lected during a 5 min period was mixed with 70%
w xperchloric-acid 10 1 and neutralized with KHCO in3
order to eliminate ectophosphatases. ATP in the per-
fusate was estimated by luciferin–luciferase method
by using a luminometer LUMAT LB 9501 EEG
.Berthold, Wildbachr Germany and a reaction kit
 .from PERSTORP Landgraaf, The Netherlands . The
lowest concentration detectable was 3 nM.
2.1. Experimental protocol
After an equilibration phase of 40 min the hearts
were perfused for 35 min with a buffer containing the
agents to be tested and subsequently for another
40 min with the hypoxic medium equilibrated with
10% O i.e. O supply was reduced to about 20% of2 2
.O -consumption of the normoxic state . The hearts2
were then reoxygenated for 15 min with the original
 .  .O 5% CO saturated medium cf. Fig. 1 and they2 2
were stained and fixed as described above. Agents:
vinblastin, cytochalasin D, and taxol were purchased
from Sigma. Vinblastine was dissolved in KHB
 y6 .10 M . Cytochalasin D and taxol were dissolved
first in 17% propanediolrwater. These stock solu-
tions were kept in the dark and added to KHB before
the experiments to a final concentration of 10y6 M.
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Fig. 1. Interstitial creatine kinase activity under hypoxia and
reoxygenation as influenced by cytoskeleton modifying agents
 .n s 5 in each group; X " SEM .
 .Propanediol 0.1 M alone had no detectable effect on
any of the evaluated parameters when used in the
corresponding dilution.
3. Results
The microtubuli stabilizing agent taxol exerted the
following actions: The functional parameters of the
  .isolated heart peak isometric systolic pressure PIP ,
 .  ..heart rate HR and coronary resistance CR were
 y6 .not detectably altered by taxol 10 M in the nor-
moxic state. In the state of hypoxia 60–70% reduc-
. tion of PIP and HR and reoxygenation full recov-
.ery , no effects of taxol on PIP, HR and CR were
visible either. In contrast, the effects of taxol on
 .enzyme CK release were dramatic: thus the pro-
nounced release of CK into the interstitial fluid in
hypoxia and the even higher release during reoxy-
 .genation was completely abolished Fig. 1 . Similarly
 .the total release venous q interstitial effluent was
significantly reduced under all experimental condi-
 .  .tions normoxia, hypoxia, reoxygenation Fig. 2 .
Thus the percentage of total CK released during the
experimental period amounted to about 3.5% of total
releasable CK in controls and to less than 1.7% under
 .the influence of taxol Fig. 3 .
The number of irreversibly injured myocytes
  ..trypan blue nuclear staining NS was less than
0.4% after the experimental period of 130 min in
controls i.e. hypoxia and reoxygenation without
.drug . This parameter was also reduced in a highly
significant manner by taxol to 0.05%.
The microtubuli destabilizing agent vinblastine
 y6 .10 M did not lead to alterations of peak systolic
pressure, heart rate and coronary resistance in the
normoxic, or in the hypoxic, or in the reoxygenated
 .Fig. 2. Total release of creatine kinase interstitialq venous
 .  .during the periods of normoxia 75 min , hypoxia 40 min and
) . reoxygenation 15 min n s 5 in each group; X "SEM. Sig-
nificant versus control, ANOVA-test, ) p - 0.05, )) p - 0.01,
))) .p - 0.002 .
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Fig. 3. Percentage of total released creatine kinase sum of all
.sampling periods, cf. Fig. 1 , percentage of trypan blue perme-
 .able heart cells NS and ratio of the two values as influenced by
cytoskeleton modulating agents n s 5 in each group; X " SEM.
) Significant versus control, ANOVA-Test, ) p - 0.05, )) p -
))) .0.01, p - 0.002 .
state. Interstitial CK release, as well as total CK
release were not significantly altered by vinblastine
 .during hypoxia and reoxygenation Fig. 2 . However,
the fraction of irreversibly injured cardiomyocytes
 .was increased by a factor of almost 3 Fig. 3 under
the influence of the agent. Correspondingly, the re-
sulting reduction in the ratio CKrNS to about 3 was
also highly significant.
In order to alter another component of the cyto-
skeleton, the actin filament destabilizing agent cyto-
chalasin D was administered the actin filament stabi-
lizing drug phalloidin could not be studied, since it is
.practically membrane-impermeant . Cytochalasin D
 y6 .10 M markedly depressed contractility and heart
 .rate in the normoxic state Fig. 4 . Hypoxia and
reoxygenation led to only minor further changes. The
increase in interstitial CK release occurring in hy-
poxia and reoxygenation was completely abolished
 .by cytochalasin D Fig. 1 and total CK release
 .strongly reduced Fig. 3 . The number of irreversibly
injured cells was also lowered, but to a higher degree
than CK release leading to a ratio CKrNS of 40 Fig.
.3 .
In order to investigate whether these apparently
beneficial changes were the consequence of the low-
ered contractility, the cardiac depressant agent BDM
 w x.butanedionmonoxim 8 was also investigated with
 .respect to its influence on CK release. BDM 15 mM
lowered contractile performance by more than 80%
and heart rate by about 60%. This depression of
Fig. 4. Effect of cytochalasin D on left-ventricular peak systolic
 .pressure PIP and heart rate in comparison with control hypoxia
 .n s 5 in each group; X " SEM .
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cardiac performance was accompanied by complete
abolition of the enhancement of interstitial CK re-
lease brought about by hypoxia and reoxygenation
  .CK release: Urg x " SEM, N s 5; 5 control:ww
nomoxic, hyoxic, reoxygenated: 3.2 " 0,8; 5.9 " 0.9;
.1.9 " 0.1; BDM: 2.6 " 0.2; 1.8 " 0.05; 0.7 " 0.1
 .cf. also Fig. 1 . Thus, the lowered CK release under
the influence of cytochalasin D can be considered as
a consequence of lower contractile performance.
ATP release which is only detectable in the inter-
stitial fluid due to the extremely low extracellular
concentration of the metabolite, might be also related
w xto the cell injury 9 and was therefore investigated
under the treatment with the cytoskeleton modulating
agents. In the absence of the agents there was a
transient increase in interstitial ATP concentration
Fig. 5. Interstitial ATP-concentration during the periods of nor-
moxia, hypoxia and reoxygenation as influenced by cytoskeleton
modifying agents five in each group; X "SEM; differences
.were not statistically significant .
from about 3–20 nM during hypoxia and reoxygena-
tion corresponding to an interstitial release of about
0.2 and 2 pmolrg Pmin. Our previous investiga-ww
tions have shown that this value underestimates the
w xactual release by a factor of about 10 10,11 . None
of the agents tested altered the extent of this release
 .significantly Fig. 5 . ATP detected in the interstitial
 .fluid might be co- released from sympathethic nerve
endings. However as investigated in five experi-
ments, ATP release elicited by tyramine administra-
 .tion 16.8 " 0.8 pmolrg , SEM was abolished un-ww
 .der b-adrenergic-blockade 3.5 pmolrg " 0.8 .ww
This indicates that it is not released from nerve
endings, and that b-responsive cells are involved.
4. Discussion
Our findings demonstrate that myocardial injury
brought about by hypoxic perfusion and reoxygena-
tion is reflected by a release of CK and nuclear
staining with trypan blue. Both parameters are sub-
stantially altered by the cytoskeleton modulating
agents. Hypoxia and reoxygenation also cause an
ATP release. However, the cytoskeleton seems not to
 .be involved in ATP release Fig. 5 . As shown in an
earlier study CK is representative for other cytosolic
w xenzymes 4 . CK release and the fraction of cells
exhibiting nuclear staining differ substantially in their
 .extent, and CK-release % of releasable CK exceeds
 .irreversible injury of cardiomyocytes % of total NS
by a factor of 8–40. This indicates CK release from
reversibly injured cells CK release without nuclear
. w xstaining , as also shown in our preceding study 1 ,
w xwhere only severe injury by Ca-paradox 3,12 led to
a ratio of one.
The particular aim of the present study was to
investigate the role of the cytoskeleton in injury
elicited by hypoxic perfusion, since modification of
hypoxic cell injury by cytoskeleton modifying agents
w xcould be expected 13 . The microtubuli destabilizing
agent vinblastine led to a marked increase factor of
.about 3 of irreversibly injured cells, where CK
release was almost unchanged and the ratio of both
parameters substantially decreased. In contrast the
tubulin stabilizing agent taxol and the actin destabi-
lizing agent cytochalasin D exhibited a marked ap-
.parent cytoprotective effect reflected in a substantial
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reduction of CK release as well as under normoxia,
hypoxia and reoxygenation. The relative amount of
irreversibly injured cells was even more reduced by
both drugs resulting in a CKrNS ratio of 40.
Thus, the extent of cell injury indicated by % CK
release exceeded the presumed irreversible injury
forty fold. The effects of taxol reflect an apparent
protection of cardiomyocytes, since contractile per-
formance and coronary flow remained essentially
unchanged, and CK release from other cells e.g.
.endothelial can be neglected. Negative inotropic ef-
fects of a 10 fold higher concentration of taxol
 y5 . w x10 M 14 are not in contrast to this observation.
On the other hand, the effects of cytochalasin D were
secondary to reduced contractile performance, since
w xthe reduction of contractile performance by BDM 8
had similar effects with regard to CK release and the
energetic state tissue content of high energy phos-
phates and DG calculated from tissue content ofATP
w x.phosphocreatine, ATP and inorganic P 10 . Thus
alteration of energy metabolism, i.e. reduction of
energy consumption and hence reduction of mis-
match between energy supply and energy demand, is
likely to explain the effects of cytochalasin. This is in
line with numerous investigations on cytoprotective
interventions which have demonstrated beneficial ef-
fects of experimental preischemic contractile depres-
sion, e.g. by Ca-channel blocking- or unspecific b-
w xblocking agents 15,16 .
The mechanism involved in the effects of taxol
presumably depends directly on its effect on the
cytoskeleton. The cytoskeleton appears to play a role
in postischemic reoxygenation injury, where en-
w xhanced cell fragility seems to be one factor 8 .
Whether or not increased cell fragility occurs in our
model of hypoxic perfusion remains open at present.
The cytoskeleton might be also involved in other
processes taking place in the ‘‘stressed’’ cells, i.e.
w xexocytosis, blebbing and shedding of blebs 17,18 .
The observations in our model of hypoxic perfused
hearts is in favour of the latter interpretation, because
the prevailing presumed reversible damage indicated
by prevailing enzyme release cannot take place
through simple membrane leakages massive Ca in-
flux through the same leakages would be deleterious
w x.4 . Taxol also seems to protect pancreas cells by
w xinhibition of membrane shedding 19 in analogy to
the protective effect observed in our study. There are
also observations suggesting a link between different
 .intracellular endosomal release processes which are
initiated by membrane stretching and depend on the
cytoskeleton, since they are altered by taxol and
w xcytochalasin B 20 . Regarding interaction of cyto-
skeleton and plasmalemma a few recent observations
indicate a dependence of ion channels and Naq–Kq
w xATPase on actin filaments 21–24 . However, find-
ings on tubulin–plasmalemma interaction have not
been published so far. Moreover, the discrepancy
regarding reversible and irreversible injury indicates
the involvement of different mechanisms. In irre-
versible injury, loss of calcium ion homeostasis as a
consequence of membrane leakages presumably plays
a crucial role. In view of our results the mechanisms
involved in reversible and irreversible injury can be
differently influenced by the cytoskeleton modifying
 .agents. Elucidation of these mechanisms of i cyto-
skeleton dependent enzyme release, which is not
resulting from irreversible cell damage as well as of
 .ii those underlying irreversible injury will be the
w xaim of further investigations 12 .
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